Drug: tasigna Quarter: 2016Q3
Total Drug/Injury Combinations: 894 Number of Pages: 45
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| TASIGNA | Vaginal haemorrhage | 1 | view events |
| TASIGNA | Vaginal lesion | 1 | view events |
| TASIGNA | Varicose vein | 1 | view events |
| TASIGNA | Vascular stenosis | 1 | view events |
| TASIGNA | Vascular stent stenosis | 1 | view events |
| TASIGNA | Vasodilatation | 1 | view events |
| TASIGNA | Venous occlusion | 1 | view events |
| TASIGNA | Ventricular tachycardia | 1 | view events |
| TASIGNA | Vertigo | 1 | view events |
| TASIGNA | Vitamin D decreased | 1 | view events |
| TASIGNA | Vitamin D deficiency | 1 | view events |
| TASIGNA | Vulvovaginal discomfort | 1 | view events |
| TASIGNA | White blood cell count abnormal | 1 | view events |
| TASIGNA | Wound complication | 1 | view events |
Total Drug/Injury Combinations: 894 Number of Pages: 45
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)